Evidence map›Paper›PMID 36790661›Full record

ArticleProbiotics and antimicrobial proteins2023

Potential Probiotic Properties of Blautia producta Against Lipopolysaccharide-Induced Acute Liver Injury.

Bingyong Mao, Weiling Guo, Xuemei Liu, Shumao Cui, Qiuxiang Zhang, Jianxin Zhao, Xin Tang, Hao Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. AnmSystems · 2026
    Article
  5. Article
  6. Article
  7. The Microbiome Modulates Corneal Wound Healing via the Induction of Cholesterol Sulfotransferase Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Changes in gut microbiota inFrontiers in microbiology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bingyong MaoState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Weiling GuoState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Xuemei LiuState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Shumao CuiState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Qiuxiang ZhangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Jianxin ZhaoState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Xin TangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China. xintang@jiangnan.edu.cn.
Hao ZhangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Jiangnan University · CNState Key Laboratory of Food Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blautia is a genus of anaerobic microbe extensively present in the intestine and feces of mammals. This study aims to investigate the influence of Blautia producta to prevent lipopolysaccharide (LPS)-induced acute liver injury (ALI) and elaborate on its hepatoprotective mechanisms. B. producta D4 and DSM2950 pretreatment decreased the activities of serum aspartate transferase (AST), and alanine transaminase (ALT) in mice with LPS treatment significantly decreased the levels of inflammatory tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) and increased the activities of antioxidative superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px). Compared with the model group, B. producta D4 and B. producta DSM2950 pretreatment slightly increased the levels of cecal propionic acid, isobutyric acid, butyric acid, valeric acid, and isovaleric acid (p > 0.05). Metagenomic analysis showed that B. producta D4 and DSM2950 pretreatment remarkably increased the relative abundance of [Eubacterium] xylanophilum group, Lachnospira, Ruminiclostridium, Ruminiclostridium 9, Coprococcus 2, Odoribacter, Roseburia, Alistipes, and Desulfovibrio in ALI mice, and their abundance is negatively related to the levels of inflammatory TNF-α, IL-1β, and IL-6 as revealed by Spearman's correlation analysis. Moreover, transcription and immunohistochemistry analysis revealed that B. producta D4 and B. producta DSM2950 intervention remarkably suppressed the transcription and expression levels of hepatic Tlr4, MyD88, and caspase-3 (p < 0.05). These data indicated that B. producta may be a good candidate for probiotics in the prevention of ALI.

Indexed as

Chemical and Drug Induced Liver InjuryProbioticsAnimalsEubacterialesInterleukin-6LipopolysaccharidesMammalsMiceTumor Necrosis Factor-alphaInterleukin-6LipopolysaccharidesTumor Necrosis Factor-alphaAcute liver injuryBlautia productaIntestinal microbiotamRNA expression

Identifiers

PMID36790661
OpenAlexW4320856104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.